Decoy Therapeutics Inc.

DCOY · Nasdaq · SIC 2834: Pharmaceutical Preparations
268
SEC Filings

Business Summary

Part I Unless the context otherwise requires, Company, we, us, and our refer to the combined organization, Decoy Therapeutics Inc. (Decoy, formerly known as Salarius Pharmaceuticals, Inc. (Salarius)), and, where appropriate, its consolidated subsidiaries. References to Legacy Decoy refer to Decoy Therapeutics Inc. prior to the Merger (as defined below), which became a wholly owned subsidiary of the Company as a result of the Merger. References to Notes refer to the Notes to Consolidated Financia...

Next Earnings

Q2 FY2026 — expected 2026-09-18

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionDCOYdiscussed_in_filing Cybersecurity
topic_mentionDCOYdiscussed_in_filing Cybersecurity
topic_mentionDCOYdiscussed_in_filing Blockchain & Crypto
topic_mentionDCOYdiscussed_in_filing Healthcare & Bio
topic_mentionDCOYdiscussed_in_filing Blockchain & Crypto
topic_mentionDCOYdiscussed_in_filing Healthcare & Bio

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-312025-12-310001193125-26-134897EDGAR62K words
2025-03-212024-12-310001615219-25-000037EDGAR—
2024-03-222023-12-310001615219-24-000025EDGAR—
2023-03-272022-12-310001615219-23-000030EDGAR—
2022-03-252021-12-310001615219-22-000028EDGAR—
2021-03-182020-12-310001615219-21-000026EDGAR—
2020-03-232019-12-310001615219-20-000014EDGAR—
2019-03-062018-12-310001615219-19-000008EDGAR—
2018-03-072017-12-310001615219-18-000018EDGAR—
2017-03-082016-12-310001615219-17-000021EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-142025-09-300001615219-25-000164EDGAR33K words
2025-08-122025-06-300001615219-25-000096EDGAR—
2025-05-142025-03-310001615219-25-000048EDGAR—
2024-11-142024-09-300001615219-24-000089EDGAR—
2024-08-092024-06-300001615219-24-000071EDGAR—
2024-05-132024-03-310001615219-24-000040EDGAR—
2023-11-092023-09-300001615219-23-000071EDGAR—
2023-08-102023-06-300001615219-23-000061EDGAR—
2023-05-112023-03-310001615219-23-000038EDGAR—
2022-11-102022-09-300001615219-22-000150EDGAR—
2022-08-052022-06-300001615219-22-000124EDGAR—
2022-05-122022-03-310001615219-22-000079EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-04-020001193125-26-139145EDGAR1K words
2026-03-050001193125-26-092748EDGAR—
2026-02-250001193125-26-068813EDGAR—
2026-01-080001615219-26-000013EDGAR—
2026-01-020001615219-26-000005EDGAR—
2026-01-020001615219-26-000003EDGAR—
2025-12-190001615219-25-000197EDGAR—
2025-11-190001615219-25-000168EDGAR—
2025-11-170001615219-25-000166EDGAR—
2025-11-130001615219-25-000162EDGAR—

268 total filings indexed. 236 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001615219
TickerDCOY
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: a8e6f48df6dd68ee1d261ff84603a6239f1e4e7f11638437880df569cfd6b650
parent: a919946f1bf846711ad3a7f4e7afc3045e2d93af2a4572b1b2d412fbf3c3920b
content hash: 54b67210e641b1f9e26bdd0e19e582ee742a2b148621a955bb7ecd0b5f08841b
signed: 2026-04-13T04:44:37.752Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf